Thoratec Issues LVAD Guidelines; WorldHeart Announces June 8 FDA Panel
This article was originally published in The Gray Sheet
Executive Summary
Thoratec expects to steadily improve infection and survival rates associated with the HeartMate XVE LVAD by issuing a series of "best practice" guidelines developed by the most experienced ventricular assist device implanters